Method compositions and apparatus for treating and preventing re

Details Method compositions and apparatus for treating and preventing re Method compositions and apparatus for treating and preventing re

1998-07-07

2000-02-01

Nutter, Nathan M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heavy metal containing doai

514494, 514499, 514501, 514502, 514617, 514630, 514635, 514639, 514641, 514646, 514647, 514648, 514657, A01N 5502, A01N 5914, A01N 5916, A01N 5920

Patent

active

060203692

ABSTRACT:
Respiratory viral infections may be effectively prevented or treated by administering an aerosol spray comprising a polyoxometalate to the lungs.

REFERENCES:
patent: 4547369 (1985-10-01), Chermann et al.
patent: 4590298 (1986-05-01), Che
patent: 4634502 (1987-01-01), Callahan et al.
patent: 4681933 (1987-07-01), Chu et al.
patent: 4759929 (1988-07-01), Chermann et al.
patent: 4839008 (1989-06-01), Hill
patent: 4841039 (1989-06-01), Chu et al.
patent: 4864041 (1989-09-01), Hill
patent: 4916122 (1990-04-01), Chu et al.
patent: 5051414 (1991-09-01), Domaille et al.
patent: 5077279 (1991-12-01), Chu et al.
patent: 5084445 (1992-01-01), Chu et al.
patent: 5093134 (1992-03-01), Murrer et al.
patent: 5093327 (1992-03-01), Domaille et al.
patent: 5512305 (1996-04-01), Abrams et al.
Rhule, J. T., et al., Chem Rev. vol. 98, No. 1, pp. 327-357, 1998.
B. Moskovitz et al, Antimicrob. Agents and Chemoth., vol. 32, pp. 1300-1303 (1988).
C. Jasmin et al, Biomedicine, vol. 18, pp. 319-327 (1973).
C. Jasmin et al, J. Natl. Cancer Inst., vol. 53, pp. 469-474 (1974).
J.-C. Chermann et al, Biochem. Biophys. Res. Comm., vol. 65, pp. 1229-1235 (1975).
G. Werner et al, J. gen. Virol., vol. 31, pp. 59-64 (1976).
D. Ablashi et al, Eur. J. Cancer, vol. 13, pp. 713-718 (1977).
H. Tsiang et al, J. gen. Virol., vol. 40, pp. 665-668 (1978).
R. Kimberlin et al, The Lancet, pp. 591-592 (Sep. 15, 1979).
M. Michelon et al, J. inorg. nucl. Chem.,vol. 42, 1583-1586 (1980).
B. Schonfeld et al, Z. Naturforsch, vol. 30b, pp. 959-960 (1975).
C. Cibert et al, Biochem. Biophys. Res. Comm., vol. 108, pp. 1424-1433 (1982).
N. Larnicol et al, J. gen. Virol., vol. 55, pp. 17-23 (1981).
M. Herve et al, Biochem. Biophys. Res. Comm., vol. 116, pp. 222-229 (1983).
R. Kimberlin et al, Arch. Virol. vol. 78, pp. 9-18 (1983).
F. Bussereau et al, Ann. Virol., vol. 134 E, pp. 487-506 (1983).
M. Souyri-Caporale et al, J. gen. Virol., vol. 65, pp. 831-835 (1984).
W. Rozenbaum et al, The Lancet, pp. 450-451 (Feb. 23, 1985).
R. Kimberlin et al, Antimicrob. Agents Chemoth., vol. 30, pp. 409-413 (1986).
J. Blancou et al, Current Chemotherapy and Immunotherapy, Proceedings of the 12th International Congress of Chemotherapy, Italy, vol. 2, pp. 1070-1071 (1981).
Kirk-Othmer Encyclopedia of Chemical Technology, 4th Ed., vol. 1, pp. 670-685 (1991).
J. Fox, ASM News, vol. 52, pp. 12-16 (1986).
M. Pepin et al, Arch. Virol., vol. 83, pp. 327-329 (1985).
D. Riesenberg, JAMA, vol. 254, pp. 2521-2529 (1985).
M. Michelon et al, C. R. Acad. Sc. Paris, vol. 274, pp. 209-212 (1972).
C. Bonissol, C. R. Acad. Sc. Paris, vol. 274, pp. 3030-3033 (1972).
T. Nemetschek et al, J. Mol. Biol., vol. 133, pp. 67-83 (1979).
R. Schinazi et al, Selective Antiviral Activity of a Silicotungstate Heteropoly Acid Against HTLV3/LAV and Herpes Simplex Virus, presented at 26th ICAAC, New Orleans, Louisiana (1986).
J. Blasecki, "Of Therapy, Toxicity and Tungstates: The anti-Retroviral Pharmacology of Polyoxometalates," in Polyoxometalates, Pope et al, Eds, Kluwer Academic Publishers, pp. 373-385 (1994).
M. Raynaud, C.R. Acad. Sc. Paris. vol. 272, pp. 347-348 (1971).
D. Dormont et al, Cancer Detection and Prevention, vol. 12, pp. 181-194 (1988).
W. Turner et al, P.S.E.B.M., vol. 138, pp. 1030-1034 (1971).
M. Alizadeh et al, J. Am. Chem. Soc., vol. 107, pp. 2662-2669, (1985).
R. Finke et al., J. Am. Chem. Soc., vol. 103, pp. 1587-1589, (1981).
C. Brevard et al, J. Am. Chem. Soc., vol. 105, pp. 7059-7063 (1983).
W. Knoth, Inorg. Chem., vol. 25, pp. 1577-1584 (1986).
R. Finke et al, Inorg. Chem., vol. 26, pp. 3886-3896 (1987).
S. Ikeda et al, Antiviral Chem. Chemother., vol. 4(5), pp. 253-262 (1993).
R. Ruprecht et al, Nature, vol. 323, pp. 467-469 (1986).
Y. Take et al, Antiviral Res., vol. 15, pp. 113-124 (1991).
D. Judd et al, Antiviral Chem. Chemother., vol. 5(6), pp. 410-414 (1994).
L. Ni et al, Antimicrob. Agents Chemother., vol. 38, pp. 504-510 (1994).
N. Yamamoto et al, Mol. Pharmacol., vol. 42, pp. 1109-1117 (1992).
M. Fukuma et al, Antiviral Res., vol. 16, pp. 327-339 (1991).
M. Cholewa et al, Life Sciences, vol. 54, pp. 1607-1612 (1994).
T.-C. Chou et al, Adv. Enz. Regul., vol. 22, pp. 27-55 (1984).
M. Dabbabi et al, J. Inorg. Nucl. Chem., vol. 38, pp. 1011-1014 (1976).
M. Droege, J. Mol Catal., vol. 69, pp. 323-338 (1991).
D. Edlund et al, Organomet, vol. 7, pp. 1692-1704 (1988).
B. Ericksson et al, Antimicrob. Agents Chemother., vol. 31, pp. 600-604 (1977).
R. Finke et al, J. Am. Chem. Soc., vol. 106, pp. 7274-7277 (1984).
M. Fischl, New England J. Med., vol. 317, pp. 185-191 (1987).
J. Groopman et al, AIDS Res. Human Retro., vol. 3, pp. 71-85 (1987).
G. Herve et al, Inorg. Chem., vol. 16, pp. 2115-2117 (1977).
C. Hill et al, in Advances in Chemotherapy of AIDS, Diaso et al, Eds., Pergamon Press, New York, pp. 33-41 (1990).
C. Hill et al, J. Med. Chem., vol. 33, pp. 2767-2772 (1990).
J. Horwitz et al, J. Org. Chem., vol. 29, pp. 2076-2078 (1964).
M. Hosoya, Antimicrob. Agents Chemother., vol. 35, pp. 2515-2520 (1991).
Kirk-Othmer Encyclopedia of Chemical Technology, 3rd Ed., vol. 21, pp. 466-483 (1983).
G. Kim et al, J. Med. Chem., vol. 37, pp. 816-820 (1994).
C. Krieg et al, Exptl. Cell. Res., vol. 116, pp. 21-29 (1978).
B. Larder et al, Science, vol. 243, pp. 1731-1734 (1989).
D. Lyon et al, J. Am. Chem. Soc., vol. 113, pp. 7209-7221 (1991).
M. Pope, Heteropoly and Isopoly Oxometalates, Sringer-Verlag, Berlin, pp. 1-181, 1983.
J. McDougal et al, J. Immun. Meth., vol. 76, pp. 171-183 (1985).
H. Mitsuya et al, Proc. Natl. Acad. Sci. USA, vol. 82, pp. 7096-7100 (1985).
H. Nishimura et al, J. Gen. Virol., vol. 70, pp. 1653-1661 (1989).
W. Ostertag et al., Proc. Natl. Acad. Sci. USA, vol. 71, pp. 4980-4985 (1974).
Pauwels et al, J. Virol. Meth., vol. 20, pp. 309-321 (1988).
D. Richman et al, N.E.J. Med., vol. 317, pp. 192-197 (1987).
R. Schinazi et al, Antimicrob. Agents Chemother., vol. 22. pp. 499-507 (1982).
S. Shigeta et al, Antimicrob. Agents Chemother., vol. 36, pp. 435-439 (1992).
S. Shigeta et al, Antiviral. Agents Chemother., vol. 3. pp. 171-177 (1992).
J. Sommadossi et al, Antimicrob. Agents Chemother., vol. 31, pp. 452-454 (1987).
T. Spira et al, J. Clin. Microbiol., vol. 25, pp. 97-99 (1987).
A. Teze et al, J. Inorg. Nucl. Chem., vol. 39, pp. 999-1002 (1977).
M. Weeks, J. Med. Chem., vol. 35, pp. 1216-1221 (1992).
R. Yarchoan et al, The Lancet, pp. 575-580, (Mar. 15, 1986).
J. T. Rhule, Chem. Rev., vol. 98, pp. 327-357 (1998).

Affiliated with

Also associated with

Rating

Method compositions and apparatus for treating and preventing re does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method compositions and apparatus for treating and preventing re, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method compositions and apparatus for treating and preventing re will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-937984